Pharma Stability: Insights, Guidelines, and Expertise
Stability data validate the shelf life, quality, and safety of a drug product over time. Regulatory agencies expect real-time data under labeled storage conditions for decision-making.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Stability studies involve multiple interconnected costs—from equipment and chambers to analytical testing and regulatory documentation. Without detailed financial forecasting, companies may face:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
A temperature excursion occurs when a product is exposed to temperatures outside its labeled storage range for any duration. Examples include:
Click to read the full article.
Modified release formulations present unique stability concerns:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Biologics often come in injectable dosage forms requiring direct contact with primary packaging materials. If the material is incompatible, it can lead to:
Click to read the full article.
Photostability cannot be treated as a separate concern from real-time stability. Several degradation mechanisms (e.g., photooxidation) require both thermal and photic input to be fully understood.
Click to read the full article.
From Pharma SOP:
Click to read the full article.